Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Consulting agrmnt
Credit agrmnt [a]
Appointed director
Inv. presentation
Quarterly results
Director departure
CC transcript
MIMEDX GROUP, INC. (MDXG) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/02/2022 8-K Quarterly results
08/02/2022 8-K Quarterly results
Docs: "MIMEDX Announces Second Quarter 2022 Operating and Financial Results"
05/03/2022 8-K Quarterly results
03/08/2021 8-K Quarterly results
11/04/2020 8-K Quarterly results
Docs: "MiMedx Announces Third Quarter 2020 Financial Results"
10/26/2017 8-K Quarterly results
07/26/2017 8-K Quarterly results
Docs: "MIMEDX ANNOUNCES RECORD RESULTS FOR THE SECOND QUARTER OF 2017 AND RAISES FULL YEAR REVENUE GUIDANCE COMPANY RECORDS 33% REVENUE GROWTH AND A 309% INCREASE IN NET INCOME OVER Q2 2016"
02/23/2017 8-K Form 8-K - Current report
10/27/2016 8-K Form 8-K - Current report
10/12/2016 8-K Quarterly results
Docs: "$64.4 Million Q3 2016 Revenue is 31% Increase Over Q3 2015 MARIETTA, Ga., Oct. 10, 2016 /PRNewswire/ -- MiMedx Group, Inc. , the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare, announced today its revenue for the third quarter of 2016. Third Quarter 2016 Revenue Highlights:"
07/26/2016 8-K Form 8-K - Current report
07/12/2016 8-K Form 8-K - Current report
04/25/2016 8-K Quarterly results
Docs: "MiMedx Announces First Quarter 2016 Results Company Records Record QUARTERLY Revenue of $53.4 Million"
04/11/2016 8-K Form 8-K - Current report
02/23/2016 8-K Quarterly results
Docs: "MiMedx Announces 2015 Record Results Company Records Revenue of $187.3 Million, Net Income of $29.4 million and EPS of $0.28 and $0.26 MiMedx Announces 2015 Record Results Company Records Revenue of $187.3 Million, Net Income of $29.4 million and EPS of $0.28 and $0.26 Marietta, Georgia, February 23, 2016, -- MiMedx Group, Inc. , the leading regenerative medicine company utilizing human amniotic membrane and other birth tissues, human skin and bone, and patent-protected processes and proprietary platforms to develop and market advanced products and therapies, announced today its record results for the full year and fourth quarter ended December 31, 2015. Full Year 2015 Highlights are:"
10/29/2015 8-K Quarterly results
Docs: "MIMEDX ANNOUNCES RECORD RESULTS FOR THIRD QUARTER OF 2015"
07/30/2015 8-K Quarterly results
Docs: "MIMEDX ANNOUNCES RECORD RESULTS FOR SECOND QUARTER OF 2015"
04/28/2015 8-K Quarterly results
Docs: "MiMedx Announces Record Results for First Quarter of 2015 and Raises Full-year Guidance COMPANY RECORDS REVENUE OF $40.8 MILLION and NET INCOME of $4.1 MILLION"
04/14/2015 8-K Quarterly results
Docs: "MIMEDX REPORTS RECORD FIRST QUARTER 2015 REVENUE OF $40.8 MILLION Q1 2015 REVENUE REPRESENTS A 108% INCREASE OVER Q1 2014"
02/26/2015 8-K Quarterly results
Docs: "MIMEDX ANNOUNCES 2014 RECORD REVENUE AND FIRST FULL YEAR OPERATING PROFIT"
10/30/2014 8-K Quarterly results
Docs: "EXHIBIT"
07/29/2014 8-K/A Quarterly results
Docs: "EXHIBIT"
07/28/2014 8-K Quarterly results
Docs: "EXHIBIT"
04/25/2014 8-K Quarterly results
Docs: "EXHIBIT"
02/26/2014 8-K Quarterly results
Docs: "Marietta, Georgia, February 26, 2014 -- MiMedx Group, Inc."
10/30/2013 8-K Form 8-K - Current report
07/31/2013 8-K Form 8-K - Current report
05/01/2013 8-K Form 8-K - Current report
03/07/2013 8-K Form 8-K - Current report
10/30/2012 8-K Form 8-K - Current report
07/26/2012 8-K Form 8-K - Current report
05/03/2012 8-K Form 8-K - Current report
02/29/2012 8-K Form 8-K - Current report
10/31/2011 8-K Form 8-K - Current report
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy